InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by SIMARD JOHN, Chairman & CEO. Officer active across 1 company, notably XBiotech Inc.. Aggregated, 13 disclosures have been recorded. Split: 0 buy · 13 sells. Total volume traded: €3.9m. Activity tracked since 14 July 2021. The latest transaction was filed on 15 October 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
17,000 shares@ US$13.32180.26% mcap5.1% of flowCommon StockSEC:0001209191-22-009745:0
39,286 shares@ US$12.450.56% mcap11.0% of flowCommon StockSEC:0001209191-21-060523:0
39,286 shares@ US$12.4511.0% of flowCommon StockSEC:0001209191-21-060523
23,681 shares@ US$13.08490.36% mcap6.9% of flowCommon StockSEC:0001209191-21-059849:0
23,681 shares@ US$13.08496.9% of flowCommon StockSEC:0001209191-21-059849
6,263 shares@ US$14.26850.10% mcap2.0% of flowCommon StockSEC:0001209191-21-058475:0
6,263 shares@ US$14.26852.0% of flowCommon StockSEC:0001209191-21-058475
9,892 shares@ US$14.68050.16% mcap3.2% of flowCommon StockSEC:0001209191-21-057877:0
9,892 shares@ US$14.68053.2% of flowCommon StockSEC:0001209191-21-057877
13,471 shares@ US$15.0630.23% mcap4.5% of flowCommon StockSEC:0001209191-21-057295:0
13,471 shares@ US$15.0634.5% of flowCommon StockSEC:0001209191-21-057295
50,000 shares@ US$18.14719.9% of flowCommon StockSEC:0001209191-21-047105
50,000 shares@ US$18.1471.02% mcap19.9% of flowCommon StockSEC:0001209191-21-047105:0
13 of 13 declarations
About SIMARD JOHN
John Simard is Chief Executive Officer of XBiotech Inc. In this role, he oversees the company's operations and defines its overall strategy. Simard plays a key role in developing new treatments and innovation in the biotechnology field. His leadership is crucial for the growth of XBiotech.
